Sponsor Pipeline

Biying Chen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07686588 Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck… Recurrent or Metastatic Head and Neck Carcinoma Not Yet Recruiting
Get alerts when Biying Chen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free